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Abstract
Pancreatic ductal adenocarcinoma (PDAC) shows a high level of basal autophagy. Here we investigated the role of
optineurin (OPTN) in PDAC cell lines, which is a prominent member of the autophagy system. To that purpose, mining
of publically available databases showed that OPTN is highly expressed in PDAC and that high levels of expression are
related to reduced survival. Therefore, the role of OPTN on proliferation, migration, and colony formation was
investigated by transient knockdown in Miapaca, BXPC3, and Suit2-007 human PDAC cells. Furthermore, gene
expression modulation in response to OPTN knockdown was assessed by microarray. The influence on cell cycle
distribution and cell death signaling cascades was followed by FACS, assays for apoptosis, RT-PCR, and western blot.
Finally, autophagy and ROS induction were screened by acridine orange and DCFH-DA fluorescent staining
respectively. OPTN knockdown caused significant inhibition of colony formation, increased migration and no
significant effect on proliferation in Miapaca, BXPC3 and Suit2-007 cells. The microarray showed modulation of 293
genes in Miapaca versus 302 in Suit2-007 cells, of which 52 genes overlapped. Activated common pathways included
the ER stress response and chaperone-mediated autophagy, which was confirmed at mRNA and protein levels.
Apoptosis was activated as shown by increased levels of cleaved PARP, Annexin V binding and nuclear fragmentation.
OPTN knockdown caused no increased vacuole formation as assessed by acridine orange. Also, there was only
marginally increased ROS production. Combination of OPTN knockdown with the autophagy inducer erufosine or
LY294002, an inhibitor of autophagy, showed additive effects, which led us to hypothesize that they address different
pathways. In conclusion, OPTN knockdown was related to activation of ER stress response and chaperone-mediated
autophagy, which tend to confine the damage caused by OPTN knockdown and thus question its value for PDAC
therapy.
Introduction
Optineurin (OPTN) is encoded by a gene on chromo-
some 10p13, which has 16 exons, 3 of which are non-
coding. After translation the protein consists of 577
amino acids (Fig. 1a, b)1,2, has an apparent size of a
67 kDa, a half-life of ~8 h, and its turnover involves the
ubiquitin proteasomal system3. OPTN consists of several
domains: a Nemo NF-κB-essential molecule -like domain,
leucine zipper motif, an LC3-interacting region, coiled-
coil motifs, an ubiquitin-binding domain, and a C-
terminal C2H2 type zinc finger motif4,5 (Fig. 1c). OPTN
interacts with itself to form homo-oligomers6 as well as
with other molecules including Ras-related protein 8
(Rab8)7, huntingtin8, myosin VI9, transferrin receptor10,
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LC3/GABARAP2, polo-like kinase 111,12, TANK binding
kinase 113 as well as many others4 (Fig. 1d). The con-
formation of certain parts of OPTN has been determined
by X-ray analysis (Fig. 1e)14–16.
OPTN has several physiological roles including mem-
brane trafficking, maintenance of the Golgi apparatus,
exocytosis and protein secretion, cell division control,
suppression of the NF-κB pathway, and host defense
against pathogens1,2,4,17. Overexpression of OPTN was
protective against H2O2 mediated cell death
7.
OPTN was identified as a selective autophagy receptor
because it binds to polyubiquitinated cargoes and brings
them to autophagosomes via its LC3-interacting
region4,18–20. Thus, it can get rid of pathogens as salmo-
nella18, defective mitochondria20, misfolded protein
aggregates21 or can have a role in tumor suppression19.
The role of OPTN in autophagy can be also independent
from ubiquitination4.
Beside all the physiological roles, mutations of OPTN or
its altered expression are associated with multiple dis-
eases, including normal tension glaucoma and primary
open-angle glaucoma22, as well as plenty of neurodegen-
erative diseases23. Diminished OPTN expression might
increase the risk of developing Crohn’s disease24 and
predisposes to the occurrence of Paget’s disease by
enhancing osteoclast differentiation, as OPTN was
Fig. 1 Structure of optineurin. Graphic illustration of optineurin at genomic (a), mRNA (b), and protein levels (c, e). a The OPTN structure at
genomic level was generated using the NCBI sequence (reference NG_012876.1 (https://www.ncbi.nlm.nih.gov/nuccore/257743476)), and the scaling
factors used were 1:400 bp (for exons) and 1:4000 bp (for introns). Together, 16 exons form the OPTN gene. b The mRNA was generated from the
same source and consists of 1734 bp. c The protein contains various structural domains, and the localization of these domains is indicated relative to
the amino acid sequence as well as to some interacting proteins (d). LZ Leucine-zipper domain, LIR LC3-interacting region, CC coiled coil domain,
UBD ubiquitin-binding domain, ZF zinc finger domain, TBK tank binding kinase, Rab8 RAB8A, Member RAS Oncogene Family, LC3/GABARAP light
chain 3/beta, GABA type A receptor associated protein. CYLD CYLD Lysine 63 Deubiquitinase, HTT huntingtin. e Crystal structure of different OPTN
domains as determined by X-ray analysis. These images were made with VMD, which is owned by the theoretical and computational biophysics
group, NIH Center for Macromolecular Modeling and Bioinformatics, at the Beckman Institute, University of Illinois at Urbana-Champaign. E.114
represents the structure of the amino acids 26–103 (HLAHP NLDTFTPEEL LQQMKELLTE NHQLKEAMKL NNQAMKGRFE ELSAWTEKQK EERQFFEIQS
KEAKERLMAL SHE). E.215 represents OPTN amino acids from 170 to 181 or LC3B interacting region (the sequence consists of SGSSEDSFVE I). E.316
shows the crystal structure of UBD spanning the amino acids 416–510 (EKVDR AVLKELSEKL ELAEKALASK QLQMDEMKQ TIAKQEEDLE TMTILRAQME
VYCSDFHAER AAREKIHEEK EQLALQL AVL LKENDAFEDG)
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identified as a regulator of bone resorption25. Increased
expression has been found in several cancers, including
pancreatic cancer (for details see “Results” section).
Pancreatic cancers are suspected to become the second
leading cause of cancer-related deaths in the United States
by the year of 203026. Pancreatic ductal adenocarcinoma
(PDAC) accounts for 90% of all diagnosed pancreatic
cancers27. PCAC has a poor prognosis with a mortality
rate that is almost equal to the incidence rate and a 5-year
survival rate of only 7% for all stages28.
Surgery remains the only potentially curative treatment
for nonmetastatic PDAC29,30. Combination chemotherapy
or targeted therapy cause only modest improvement in
survival29,31,32. This background is reason for modern
strategies pending on new biomarker identification and
patient selection31.
The role of autophagy in PDAC is quite complex, with
several studies indicating that autophagy has a tumor
suppressive role and others reporting an onco-stimulatory
effect33. An exciting point about PDAC is that primary
tumors and cell lines show elevated basal autophagy34, yet
the role of autophagy in PDAC is still to be clarified35.
Here, we investigated the role of OPTN in PDAC cells.
After transient knockdown, alterations in cellular prop-
erties were observed including proliferation, migration,
and colony formation as well as induction of autophagy
and apoptosis. Furthermore, OPTN expression of PDAC
patients was used from the Human Protein Atlas data-
base. Our results hint to OPTN as a versatile factor in the
progression of cancer in general and of PDAC in
particular.
Results
Optineurin is overexpressed in pancreatic cancer
For assessing the expression of OPTN in human can-
cers, publically available databases were explored. An
overview of the RNA-seq data provided by The Cancer
Genome Atlas (TCGA) revealed high expression of the
OPTN gene across several tumor types (Fig. 2a)36.
Remarkably, pancreatic cancer was associated with the
second highest OPTN expression of all tumor tissues,
superseded only by renal cancer, as shown in Fig. 2a36.
The median number of fragments per kilobase of exon per
million reads (FPKM) was 25 for pancreatic cancer.
Increased OPTN expression was related to a significantly
reduced survival probability of PDAC patients (P= 0.014;
Fig. 2b)37–39.
As the reported high expression could render OPTN an
attractive target for therapy, we became interested in its
function. OPTN is an autophagy receptor, the importance
of which is substantiated by the observation that almost
all members of the autophagy process show increased
expression in PDAC (Fig. 2c). As found from a TCGA
cohort with a sample size of 179 PDAC patients, most of
the autophagy genes show genomic expression above
average, as indicated by >7.5 log2 rsem (RNA-Seq by
expectation maximization). Among these genes, OPTN
showed the second highest expression superseded only by
sequestosome 1(SQSTM1) (Fig. 2c). Prompted by this
information, we set out to discover the role of OPTN in
PDAC using a panel of PDAC cell lines.
Effect of OPTN knockdown on cellular functions
Target specific siRNA (12.5 nM) knocked down OPTN
expression successfully in three pancreatic cancer cell
lines (Miapaca, Suit2-007 and BXPC3). The knockdown
efficacy at mRNA level as tested by qRT-PCR (Fig. 3a),
was comparably high in all three cell lines ranging from
95% (BXPC3) to >96% (Miapaca and Suit2-007).
At protein level, as determined by western blot (Fig. 3b),
the knockdown efficiency ranged from 80% (Miapaca) to
70% (BXPC3) and 50% (Suit2-007). The subsequent
experiments focused on the effect of OPTN knockdown
on cellular functions.
As shown in Fig. 3c, proliferation was not significantly
altered by OPTN knockdown in the three cell lines. In
partial contrast, migration was significantly increased in
BXPC3 and Miapaca cells, but not significantly in Suit2-
007 cells (Fig. 3d). The most striking effect was observed
for colony formation (Fig. 3e), which was reduced to 32.5,
48, and 45% in Miapaca, BXPC3 and Suit2-007 cells,
respectively, in comparison with siRNAcontrol (100%).
Modulation of genes in response to OPTN knockdown
To possibly explain the changes in cellular functions
following OPTN knockdown, a microarray was performed
in two cell lines (Miapaca and Suit2-007). A cutoff (1.5-
fold) was used for differentiating between significant and
background changes in expression. The results were
analyzed by Ingenuity Pathway Analysis (IPA) software
and revealed 293 genes being significantly modulated in
Miapaca compared with 304 genes in Suit2-007 cells.
From these, 52 genes were significantly deregulated in
both cell lines as shown by the Venn diagram (Fig. 4a).
Overall 38 of these 52 genes were downregulated (e.g.,
CDK6: −2.38-fold in Miapaca and −1.76-fold in Suit2-
007; CCNE1: −1.79-fold in Miapaca and −1.60-fold in
Suit2-007; and protein arginine methyltransferase 6
(PRMT6): −2.47-fold in Miapaca and −1.76-fold in Suit2-
007). In addition, 11 of 52 genes were upregulated (e.g.,
BCAT1: 1.7-fold in Miapaca and 1.5-fold in Suit2-007,
claudin 1 (CLDN1): 1.95-fold in Miapaca and 1.85-fold in
Suit2-007; and Lysosomal associated membrane protein 2
(LAMP2): 1.6-fold in both cell lines). Finally, three genes
were differently modulated (e.g., interferon- induced
transmembrane protein 3 (IFITM3): 1.5-fold in Miapaca
and −1.713-fold in Suit2-007). All modulated genes are
given in Supplementary Tables 1–3.
Ali et al. Cell Death Discovery           (2019) 5:128 Page 3 of 15
Official journal of the Cell Death Differentiation Association
Canonical pathway analysis revealed the activation of
phospholipase C and thrombin signaling in both cell
lines. From the other 11 canonical pathways identified
by IPA, the majority was altered in Miapaca cells, only
(Fig. 4b).
For validating the effect on cell cycle in Miapaca cells,
the DNA distribution was analyzed by flow cytometry. As
shown in Fig. 4c, there were moderate reductions in cells
undergoing G1 and G2/M phases, and a mild increase in S
phase cells (Fig. 4c, d). The pre-G1 (subG1) fraction, as an
indicator of cell death, was increased in OPTN
knockdown samples with a percentage of 12.7% compared
with 2.7% in the siRNAcontrol when analyzed by flowing
software. These observations correlate with reduced
expression of CDK6 mRNA in all three cell lines (Fig. 4e),
and of CDK6 protein in Miapaca cells (Fig. 4f). Con-
comitantly, a less prominent reduction of CDK4 at mRNA
and protein levels was observed. For cyclins, a less uni-
form modulation was observed, as cyclin D1 was
increased in Miapaca (mRNA and protein) and Suit2-007
cells (mRNA), but decreased in BXPC3 cells (mRNA).
Similarly, cyclin D3 was increased in Miapaca, but slightly
Fig. 2 OPTN expression from publically available human cancer data. a Overview of the RNA-seq data in TCGA of 17 cancer cohorts showing
the highest OPTN expression in renal cell carcinoma followed by PDAC (expressed in terms of median FPKM). b Kaplan–Meier curves of high and low
OPTN expression in PDAC versus the survival of patients (log rank p-value (1.4e-2). Both a and b data were retrieved from human protein atlas
(https://www.proteinatlas.org/ENSG00000123240-OPTN/pathology/tissue/pancreatic+cancer). c Expression of autophagy related genes and
receptors in the PDAC cell cohort with a sample size of 179 patients. The mean control expression is indicated by the straight line across all groups.
All expression levels shown are >7.5 log2 rsem (Rna-Seq by Expectation Maximization)
Ali et al. Cell Death Discovery           (2019) 5:128 Page 4 of 15
Official journal of the Cell Death Differentiation Association
decreased in Suit2-007 and BXPC3 cells (mRNA). Fur-
thermore, p27 was increased in Miapaca cells at protein
level in response to OPTN knockdown (Fig. 4f).
Analysis of upstream regulators showed matching
upregulation of activating transcription factor 4 (ATF4),
nuclear protein 1, uncoupling protein 1, Combgap, KRAS
Fig. 3 Effect of OPTN knockdown on PDAC cellular functions. The three columns represent results from BXPC3 (left), Miapaca (middle) and Suit2-
007 (right). a, b mRNA and protein expression of OPTN in three pancreatic cell lines determined by qRT-PCR and WB at 48 h post siRNA transfection.
All specific knockdown samples were compared with untreated and treated controls. Samples were normalized to GAPDH for qRT-PCR and to β-actin
for WB. Calculation for qRT-PCR was done using the ΔΔCT method and imageJ was used to measure band densities for western blot. c Cytotoxic
effect of OPTN silencing on three pancreatic cancer cell lines post transfection with the MTT assay. Absorbance was measured at 540 nm wavelength
with a reference of 690 nm. d Migration assay showing the number of migrating cells following transfection using a transwell 2 compartment model
that was determined by cell titer blue (Excitation 560/15 and Emission 590/ 20). The assays were done in triplicate and the results represent their
average. e Colony formation assay was started at 48 h post transfection and shows the number of colonies as well as that of the nonspecific control
after 7–10 days. The assay was done in quadruplicate and the data represent the respective average with standard deviation. Statistical analysis for all
tests was done with Student’s t-test and one way Anova with p values ≤ 0.05 considered significant. *p < 0.01, **p < 0.001, ***p < 0.0001
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Proto-Oncogene-GTPase (KRAS), claudin 7, platelet
derived growth factor B, and NK2 Homeobox 3. All other
upstream regulators showed divergent results between the
two cell lines (Fig. 4g).
OPTN knockdown activates ER stress and chaperone-
mediated autophagy
As ATF4 was found among the highly modulated
upstream regulators of OPTN, the related network was
Fig. 4 Microarray data with modulation of genes in response to OPTN-KD. a The Venn diagram shows 52 genes modulated in both Miapaca
and Suit2-007 cells, with 1.5-fold change taken as cutoff for analysis (detailed gene lists are shown in Supplementary tables 1, 2, 3). b Heat map
generated by IPA software showing 13 modulated canonical pathways, which are affected by the knockdown in either of the cell lines, with
activation Z scores ranging from −2.8 to 2. c Cell cycle distribution of propidium iodide staining by flow cytometry in Miapaca cells, as calculated by
flowing software. d The bar graph shows the distribution of Miapaca cells according to the cell cycle stages as calculated by flowing software and
presented as % of cells. e qRT-PCR data showing the expression of cell cycle genes (CDK6, CDK4, CCND1, CCND3) following OPTN-KD in the three
PDAC cell lines BXPC3, Miapaca and Suit2-007 in comparison with siRNA control as calculated by the ΔΔ CT method. f WB results of various CDKs in
response to OPTN-KD in Miapaca cells. Analysis of the band density was done by ImageJ software and corrected to β-actin and to negative siRNA as
control. g Heat map of the upper 30 common upstream regulators following OPTN-KD in Miapaca and Suit2-007 cells according to the activation Z
score generated by IPA software
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studied more closely. This analysis showed activation of
several ATF4 network genes, which, however, differed in
modulation between the two cell lines, except for ASNS
and branched chain amino acid transaminase 1 (BCAT1)
(Fig. 5a). Interestingly, at mRNA level, ATF4 was upre-
gulated only in Miapaca cells; however, at protein level, it
was distinctly higher expressed in Suit2-007 than in
Miapaca cells (3.3 vs. 1.4-fold; Fig. 5b). Other proteins of
the ER stress response, as phosphorylated and unpho-
sphorylated eIF2α and pPERK echoed this relationship,
except for ATF6α, which was higher expressed in Miapaca
than in Suit2-007 cells. The differential activation of the
ER pathway at mRNA and protein levels was associated,
however, with a highly similar activation of apoptosis, as
indicated by the cleaved PARP levels (Fig. 5b). In line with
PARP cleavage, staining of the Miapaca cells with
Annexin V-FITC showed a higher population of early and
late dead cells (Fig. 5c), while staining with Hoechst dye
revealed nuclear fragmentation and shrinkage following
OPTN knockdown (Fig. 5d). Staining of Suit2-007 and
Fig. 5 OPTN knockdown causes activation of ATF4 and other members of the ER stress-signaling pathway, chaperone-mediated
autophagy and apoptosis. a Heat map of genes in the ATF4 network (IPA software) for Miapaca and Suit2-007 cells with the respective fold
changes in expression. b WB analysis of the different antibodies in the ER stress-signaling pathway including pEIF2α, ATF6, pPERK and ATF4 as well as
cleaved PARP. c Miapaca cells stained with Annexin V-FITC show increased numbers of apoptotic cells in the OPTN KD sample as compared with
nonspecific control and as detected from the percentage of gated cells in the lower right quadrant. d Staining of Miapaca cells with Hoechst
33248 stain 48 h following transfection with siRNA. OPTN samples show nuclear abnormalities in terms of shrinkage and fragmentation. e Analysis of
the expression of HSP90 and LAMP2 as regulators of chaperone-mediated autophagy (CMA) by immunoblotting 48 h post transfection with siRNA.
Analysis of the band density was done by ImageJ software and corrected to β-actin as loading control and to negative siRNA as the main control
Ali et al. Cell Death Discovery           (2019) 5:128 Page 7 of 15
Official journal of the Cell Death Differentiation Association
BXPC3 nuclei with Hoechst dye showed similar changes
regarding fragmentation and shrinkage (Supplementary
Fig. 1A). Annexin V-FITC staining of Suit2-007 and
BXPC3 cells showed a mild increase in the number of
apoptotic and necrotic cells in knockdown samples when
compared with siRNA control (Supplementary Fig. 1B).
In addition, OPTN knockdown caused modulation of
autophagy controlling genes. As revealed by microarray,
several heat shock proteins (HSPE1, HSPA1A/HSPA1B
and HSP90AB1) showed downregulation, and LAMP2, a
main player in chaperone-mediated autophagy, was
upregulated (Supplementary Table 2). These data were
confirmed at protein level for total HSP90 and LAMP2 in
all three cell lines (Fig. 5e).
For detecting autophagy in a cellular assay, acridine
orange was used to visualize changes in the frequency of
acidic vacuoles. However, no clear differences were
observed between control and OPTN knockdown PDAC
cells (Supplementary Fig. 2A, B). Furthermore, a DCFH-
DA-based flow cytometric analysis was used to check for
reactive oxygen species (ROS) production. In BXPC3 and
Miapaca cells, this method revealed a minute increase in
ROS production when comparing siRNAOPTN versus
siRNAcontrol exposure. However, no effect was detected in
Suit2-007 cells (Supplementary Fig. 3).
Drugs alter the expression of OPTN
As OPTN knockdown influences genes involved in
autophagy and apoptosis, two drugs were selected, which
affect these cellular processes. Exposure of Miapaca and
Suit2-007 cells to erufosine and LY294002, which differ-
ently influence autophagy, was followed at mRNA and
protein levels as well as for their effect on proliferation.
Erufosine caused concentration dependently increased
mRNA transcription of OPTN, which was less prominent
in Miapaca than in Suit2-007 cells. A similar increase was
seen for mRNA levels of LC3B, which, however, were
lower in Suit2-007 than in Miapaca cells (Fig. 6a).
LY294002-induced concentration dependently increased
mRNA transcription of OPTN, which was more distinct
in Miapaca than in Suit2-007 cells, but LC3B mRNA
levels were not significantly increased in Miapaca and
even decreased in Suit2-007 cells (Fig. 6a). At protein
level, erufosine caused a 40% reduction of OPTN levels in
Miapaca but a 1.6-fold increase in Suit2-007 cells. Con-
comitantly, the concentrations of LC3B were increased in
both cell lines (Fig. 6b). LY294002 caused a uniform
increase of OPTN in both cell lines, but no effect (Mia-
paca) and a slight reduction (Suit2-007) in LC3B levels
(Fig. 6c). Both drugs caused an antiproliferative effect in
the PDAC cell lines. The effect of erufosine was more
pronounced in Miapaca than in Suit2-007 cells; whereas
that of LY294002 was higher in Suit2-007 than in Miapaca
cells (Fig. 6d). In combination with OPTN knockdown,
however, erufosine exposure of Miapaca and Suit2-007
cells caused no additional decrease in OPTN mRNA or
protein levels compared with OPTN knockdown alone
(Supplementary Fig. 4A, B). Equivalent results were
observed for the combination of OPTN knockdown and
exposure to LY294002 (Supplementary Fig. 4A, C). For
LC3B, there was no significantly increased concentration
at mRNA and protein levels when OPTN knockdown was
combined with either erufosine or LY294002 (Supple-
mentary Fig. 4A, D).
The observed additive interaction effects were con-
firmed by respective studies on the proliferation of Mia-
paca and Suit2-007 cells in response to erufosine,
LY294002, or knockdown of OPTN alone, or combination
of OPTN knockdown with either erufosine or LY294002
exposure (Supplementary Fig. 4E).
Discussion
Physiologically, OPTN has a function as autophagy
receptor and its presence stimulates autophagy4. In
addition, OPTN is known for its role in neurodegenera-
tive diseases as amyotrophic lateral sclerosis and open
angle glaucoma23. Interestingly, autophagy plays a role in
neurodegenerative diseases as well as in cancer40. Based
on publically available data we found that OPTN is highly
expressed in cohort studies of 17 cancer types, with the
highest expression in renal followed by pancreatic cancer,
and the lowest expression detected in prostate cancer36.
In addition, when mining TCGA, OPTN was the second
most expressed gene in PDAC from all autophagy related
genes. Thus, we investigated the role of OPTN in PDAC, a
cancer with almost identical incidence and mortality rates.
In this first study on the role of OPTN in experimental
pancreatic cancer, it was tempting to reduce OPTN levels,
which are generally increased in PDAC, by a knockdown
strategy in order to investigate its value as therapeutic
target. Following successful knockdown in three PDAC
cell lines, changes in cancer growth related cellular
properties were recorded. They were used as surrogate for
a response of PDAC in vivo. In addition, changes in gene
expression caused by OPTN knockdown were recorded
by a microarray.
The knockout of other autophagy genes as ATG5 was
associated with increased proliferation, migration and
colony formation in mouse embryonic fibroblast and NIH
3T3 cells41,42. In contrast, knockdown of OPTN had a
minor and nonsignificant effect on the proliferation of
pancreatic cancer cells, caused slightly but significantly
increased migration in two of three PDAC cell lines and
decreased colony formation distinctly in all three pan-
creatic cancer cell lines when compared with nonspecific
siRNA control.
In order to understand the mechanisms that govern
these alterations, a microarray was performed in two
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PDAC cell lines after transient OPTN knockdown to
obtain a comprehensive analysis of related mRNA
expression changes. With regard to genes, which were
modulated significantly in both cell lines (n= 52), 11
genes were found to be related to cell movement and
motility. In addition, 2 of these 11 genes were related also
to colony formation. From these 11 genes, 4 are known
for their relationship to cancer progression: they include
BCAT1, which was more than 1.5-fold upregulated in
both cell lines. Interestingly, knockdown of BCAT1 was
associated with reduced migration of nasopharyngeal and
ovarian cancer cells43,44. Another gene was CLDN1,
which was upregulated more than 1.8-fold in both cell
lines. CLDN1 is a member of the tight junction family of
genes and has attracted attention because of its altered
expression in many cancers as well as its association with
cellular properties (invasion, migration) indicating cancer
progression, which are normalized upon its knockdown in
breast and lung cancer cells45,46. Further, PRMT6 was
downregulated more than 1.7-fold in both cell lines.
PRMT6 knockdown reduced the number of colonies in
U2OS osteosarcoma cells47 as well as in ZR75 and MCF7
Fig. 6 Effect of drugs on the expression of OPTN. a mRNA expression of OPTN and LC3B in the two pancreatic cell lines Miapaca and Suit2-007, as
determined by qRT-PCR at 48 h post siRNA transfection. All specific knockdown samples were compared with corresponding controls (untreated cells
as a control of erufosine and the DMSO (vehicle) treated cells in case of LY294002). Samples were normalized to GAPDH for qRT-PCR. Calculation for
qRT-PCR was done using the ΔΔCT method. Statistical analysis for all tests was done by two-way Anova with significance considered for p values ≤
0.05; significance is shown by an asterisk over the corresponding bar. bWB of Miapaca and Suit2-007 cells treated with different concentrations of the
autophagy inducer erufosine 1 day following transfection with specific or nonspecific siRNA for OPTN. A total of 10–30 μg of protein were loaded per
sample and the OPTN and LC3b expression levels were assessed. cWB of Miapaca and Suit2-007 cells treated with the autophagy inhibitor LY294002;
shown are the expression of OPTN and the autophagy marker LC3B. d MTT assay of erufosine and LY294002 on cell survival (absorbance 540/690)
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breast cancer cells overexpressing proline-, glutamic acid-
, and leucine-rich protein 148. Moreover, PRMT6 was
found to regulate embryonic stem cell identity by mod-
ulating pluripotency genes and inducing expression of
differentiation markers49. In contrast, overexpression of
PRMT6 was associated with reduced colony formation in
breast and prostate cancer cells50. Finally, IFITM3 was
1.5-fold upregulated in Miapaca and 1.7-fold down-
regulated in Suit2-007 cells. IFITM3 is known as part of
the cellular defense against influenza infection, but also
plays a role in cancer progression as its knockdown sup-
pressed migration and invasion in gastric cancer cells51.
In addition to these functions influencing cell behavior,
the microarray on PDAC cells with OPTN knockdown
revealed induction of ER stress and chaperone-mediated
autophagy. The activation of these cellular systems could
be interpreted as adaptive mechanisms elicited in
response to OPTN knockdown. In this perception (see
Fig. 7), OPTN knockdown causes inhibition of autophagy.
The PDAC cells, however, try to overcome this situation
by releasing ER stress, as indicated by increased ATF4
levels and related signaling molecules including pPERK,
(p) eIF2α and ATF6. The central role of ATF4 in ER stress
and in inducing autophagy in response to hypoxic con-
ditions has been well documented52–54. ROS contribute to
autophagy induction55.
Further, heat shock proteins HSP90AB1, HSPA1A/
HSPA1B, HSPE1 were downregulated following knock-
down of OPTN. HSP90 has a regulatory role in the cha-
perone complex transferring damaged and misfolded
proteins to the lysosome for chaperone-mediated autop-
hagic (CMA) degradation. CMA is another form of
autophagy, where proteins are transported directly from
cytosol to the lysosomal lumen via interactions with
chaperones located in their membrane and via a protein
translocation complex56. The concomitant reduction of
HSP70 levels presumably further weakens the chaperone
complex, which plays a central role through its capability
to recognize the amino acid consensus sequence of mis-
folded and damaged proteins56. LAMP2 was twofold
upregulated following OPTN knockdown. This protein is
the docking station for HSP70 and imports proteins tag-
ged for degradation into the lysosomes. It is conceivable
that the twofold increased expression at mRNA and
protein levels was triggered by the diminished chaperone
complex. In addition, ER stress may be responsible for
LAMP2 induction57. Apart from the role of HSP90 in
CMA, specific inhibitors of HSP90, as geldanamycin, may
induce autophagy58.
Apoptosis was found to be upregulated in all cell lines in
response to OPTN knockdown as proven by increased
cleaved PARP expression, fragmentation of the nuclei by
DAPI staining and increased Annexin V binding in
respective pancreatic cancer cells. In this context, autop-
hagy inhibition was found to induce apoptosis through P53
and ER stress59. Li et al. demonstrated that withaferin A, a
biologically active extract, induced ER stress mediated
apoptosis through inhibition of lysosomal autophagic and
proteosomal degradation60. Another study revealed a switch
that decreases apoptosis in favor of protective autophagy in
methotrexate-resistant choriocarcinoma cells. This change
was indicated by ER stress through the PERK/ATF4 path-
way, or by ROS production through JNK/p62 signals61,
which are both capable to induce autophagy.
Owing to these rescue mechanisms that counteract
autophagic inhibition and restore autophagy back to basal
levels, we did not find many cellular effects that could be
related to autophagy. Any of these mild effects found in
response to OPTN knockdown were more pronounced in
Miapaca than in Suit2-007 cells. The sub lying reason could
be that Suit2-007 cells have undergone more mutations than
Miapaca cells and therefore show less dependency on
internal signaling. The effect on different pancreatic cellular
functions following OPTN-KD was mild. The most impor-
tant changes following knockdown are summarized in Fig. 7.
Contrasting with the mild changes related to autophagy,
the cell cycle was clearly changed in Miapaca cells in
response to OPTN knockdown. In line with the altered
G1/S and G2/M checkpoint regulation described by our
IPA analysis, there were increased levels of p27, which in
Fig. 7 Scheme of the response of PDAC cells following OPTN KD.
OPTN knockdown triggered inhibition of autophagy and caused
increased migration and reduced colony formation. PDAC cells tried
to reverse autophagy inhibition by activating different pathways; i.e.,
by ER stress as indicated by activation of the PERK/EIF2-α /ATF4
pathway, by stimulating CMA as manifested by upregulation of
LAMP2, and by a low increase in ROS production. Cells which could
not reverse the consequences of OPTN knockdown underwent
apoptosis
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conjunction with reduced CDK6 levels caused an increase
in non-phosphorylated cyclin D1. Concomitantly, there
were reduced percentages of G2/M and post G2/M pha-
ses, as the cell cycle did not move further after reaching
the S phase. In this scenario, the reduction observed for
the G1 phase corresponds to the increase seen for the Pre-
G1 phase as these cells probably underwent apoptosis.
Although OPTN is part of the autophagy system,
autophagy was only mildly affected in response to OPTN
knockdown. This was surprising because a decreased
OPTN level was expected to be in imbalance with cellular
LC3 levels, for which OPTN has a binding site (Fig. 1c, d).
We thus speculate that other autophagy receptors as e.g.,
SQSTM1/p62 took over and replaced the function of
OPTN. Therefore, two drugs were used, which modulate
autophagy in a reverse manner.
LY294002 is a well-known inhibitor of phosphatidylino-
sitol 3-kinase (PI3K) that acts on the ATP binding site of
the enzyme62. It was chosen as PI3K is required for
autophagy and inhibition of PI3K with LY294002 can
inhibit autophagic sequestration63. Erufosine, on the other
hand, is a potent inhibitor of mTOR and inducer of
LC3B64,65. As expected, erufosine increased the expression
of LC3B in both cell lines, whereas LY294002 caused no or
a depressive effect on this indicator of autophagy66. How-
ever, both drugs were largely ineffective in reversing the
knockdown caused by siRNA against OPTN. Further, we
had anticipated that the upregulation of LC3B by erufosine
would enlarge the imbalance between OPTN and LC3B.
However, the erufosine effect on LC3B levels was not
antagonized by OPTN knockdown, indicating that the two
autophagy proteins are regulated differently. Taken toge-
ther, the influence of the two drugs on LC3B was not
paralleled by their influence on OPTN and in combination
with OPTN knockdown, the two drugs caused additive
interactions; hence it is plausible that the two drugs and
OPTN knockdown serve different pathways.
The autophagy receptor OPTN is highly expressed in
many human cancers including pancreatic cancer. Its
knockdown in a panel of PDAC cells was related to mildly
increased migration and distinctly reduced colony for-
mation. In response to its knockdown, different rescue
mechanisms became active; namely ER stress response
and chaperone-mediated autophagy. These mechanisms
reduce the potential damage caused by the gene’s
knockdown. Finally, OPTN knockdown probably influ-
ences pathways different from those of erufosine and
LY294002 in modulating autophagy.
Materials and methods
Cell lines and cell culture condition
Three human pancreatic adenocarcinoma cell lines were
cultured in RPMI-1640 (BXPC3, Suit2-007) and DMEM
(Miapaca) medium (Invitrogen and Sigma Aldrich,
Germany respectively). All media were supplemented with
10% fetal bovine serum and L-glutamine (2mM), penicillin
(100 IU/ml) and streptomycin (100 μg/ml) (Invitrogen,
Karlsruhe, Germany). The cells were passaged routinely
using 0.25% Trypsin/EDTA solution and maintained under
standard incubation conditions (5% CO2, 37 °C) in a
humidified atmosphere. Cell lines were authenticated using
Multiplex Cell Authentication by Multiplexion (Heidelberg,
Germany) as described recently67. The SNP profiles mat-
ched known profiles or were unique.
Small interfering RNA (siRNA) experiments
Human OPTN siRNA (siRNAOPTN) was purchased
(Invitrogen, Germany). siRNA seq (5′- 3′) sense: GGA
AGU UUA CUG UUC UGA U (dT) (dT); antisense: AUC
AGA ACA GUA AAC UUC C (dT) (dT)). AllStars siRNA
serving as a non-targeting siRNA control was purchased
from Qiagen, Germany. Cells were seeded at pre-
optimized cell density in a six-well plate (8–10 × 104/
2000 μl), 24 h later siRNA was added in OptiMEM media
to a final concentration of 12.5 nM using lipofectamine
RNAimax (Invitrogen, Germany) as a transfection agent.
Cells were incubated for 48 h under standard conditions
until start of subsequent experiments.
Cell viability assay
Viability of selected cell lines, following knockdown by
siRNAOPTN and siRNAcontrol, or after treatment with
erufosine (gift from Prof. H. Eibl, Max Planck-Institute of
Biophysical Chemistry, Goettingen, Germany) or
LY294002 (Cayman Chemical, USA) was tested by the
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenylte-
trazolium bromide) assay as described before68.
Migration assay
The migratory behavior of pretreated pancreatic cancer
cells by siRNA was studied by seeding cells in a 2 com-
partment model separated by 8 μm pore size poly-
carbonate membranes (Millicell, Millipore, Schwalbach,
Germany) in a 24-well plate.
The bottom layer of the plate consisted of 700-μl media
with 20% FCS. Then, tumor cells (0.5–1 × 105 cells/300 μl
optiMEM media) were seeded in the upper compartment.
After 48 h, cell titer blue (Promega Gmbh, Mannheim,
Germany) was added into the lower compartment (140 µl)
at a ratio of 1/5 of the total amount of media contained.
Fluorescence emitted by migrating viable cells due to their
ability to reduce the dye Resazurin into the fluorescent pink
dye Resorufin was estimated using a fluorometer at wave-
lengths (560/20) for excitation and 590/10) for emission.
Colony formation assay (CFA)
The cells were treated for 48 h, harvested and counted.
Cells were then transferred into semi-solid medium
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containing 0.8% methylcellulose (MC) and 40% FCS, and
plated onto 24-well plates (0.4 ml/well, with a final
number of 100, 250, and 500 cells for Suit2-007, Miapaca,
and BXPC3, respectively). These were incubated under
usual cell culture conditions (37 °C, 5% CO2 in humidified
air) and colonies were counted under the microscope after
7–10 days. Clusters of ≥10 cells were counted as colony.
Data were represented as a percentage of the untreated
control colony forming units (CFU).
Cell cycle assay
The distribution of DNA following knockdown was
assessed using Propidium iodide staining and flow cyto-
metry. Shortly, treated cells were harvested and resus-
pended in 0.1 ml of PBS (≈2 × 105 cells) after 48 h
followed by the addition of 1.4 ml ice-cold ethanol (70%)/
sample for fixation. The cells were incubated for 2 h at 4 °
C, then washed, resuspended in PBS containing RNase A
(1 mg/ml) for digesting any contaminating RNA and
incubated for 30 min at 37 °C. Subsequently, PI (50 µg/ml)
was added to the cells, and analysis was done immediately
using a FACS Calibur (BD Biosciences, San Jose, CA,
USA). Ten thousand cells (events) were analyzed from
each sample, and the cell’s distributions in G0/G1, S and
G2/M phases of cell cycle were calculated by flowing
software.
RNA isolation and cDNA synthesis
After 48 h of exposure, the treated cells were harvested
and washed; total RNA was extracted from the cell pellets
with RNeasy Mini Kit (Qiagen, Hilden, Germany) fol-
lowing the manufacturer’s protocol. Concentrations of the
extracted RNA were measured using a Nanodrop spec-
trophotometer (Nanodrop Technologies, Germany), and
1000 ng RNA was used to synthesize complementary
DNA (cDNA) by using reverse transcriptase (Revertaid
enzyme, Thermo Scientific, Schwerte, Germany). The
cDNA samples were used as a template for further real-
time PCR amplification and analysis.
Quantitative real-time RT-PCR
Modulation of OPTN expression (for primers and
probes used, see Supplemantary Table 4) following gene
knockdown with siRNA was investigated by qRT-PCR.
Briefly, 5 μl of LC480 2X Master Mix (Roche, Mannheim,
Germany) was used in the amplification procedure of the
cDNA sample, with 0.2 μl of each of the primers, 0.1 μl of
the appropriate probe from the Human Universal Probe
library (Roche, Mannheim, Germany) and 2.5 μl of water
per reaction and 2 μl of the cDNA. The mixture was
added into 384-well plates with a total volume of 10 μl/
well. Each sample was represented in triplicate. GAPDH
was used as reference gene in the normalization process of
the corresponding sample. Corresponding changes in the
expression levels of selected genes were calculated by
2ΔΔCT method.
Western blot analysis
At 48 h following treatment of pancreatic cancer cells by
siRNA, erufosine or LY294002, the cells were harvested
from six-well plates and washed with PBS. The cell pellets
were thoroughly suspended in an adequate volume of lysis
buffer consisting of RIPA buffer, complete protease
inhibitor cocktail tablets (Roche, Mannheim, Germany),
phosphostop tablets, and sodium vanadate. The samples
were kept under constant agitation for 30min at 4 °C,
then centrifuged for 20min (14000 rpm, 4 °C). Afterward,
the supernatants were collected and the protein con-
centration was estimated using the Pierce Protein Assay.
The calculated total protein lysates (20–30 μg) were added
together with a DTT detergent and 4X dye to be dena-
tured for 5 min (99 °C, 350 rpm) and thereafter were
subjected to electrophoresis process using a 4–12% gra-
dient polyacrylamide SDS gels in a 1X Laemmli running
buffer. Transfer of proteins to PVDF membranes was
done using a wet blotting system. The membranes were
subject of test for several proteins using specific primary
antibodies: OPTN (c2) (sc-166576, G2315), OPTN
(D2L8S) (cs- 58981 S), ATF4 (sc-2280), ATF6 (sc-22799),
cdk6 (cs-3136), cdk4 (cs-12790), cdk1 (Ab-133327), EIF2-
α (cs-9722), pEIF2-α (cs-9721), pPERK(sc-32577),
LAMP2 (cs-49067S), LC3B (cs-2775S), HSP90 (C45G5)
(cs-4877), P27 kip (cs-2552), Cyclin D1 (cs-2978), cleaved
PARP (cs-9541s), β-actin; mouse monoclonal antibody
(sc-47778), and β-actin; goat polyclonal antibody (sc-
1615). A corresponding secondary antibody was added
and then the immunoblots were developed using an ECL-
system (Amersham Pharmacia Biotech, Munich, Ger-
many). Relative concentrations to β-actin, which was used
as the loading control for whole cell lysates, were eval-
uated by densitometric analysis of images using the
ImageJ software.
Microarray analysis
Total RNA was eluted in Rnase free water. The
microarray was performed by the genomics and pro-
teomics core facility in the DKFZ using Illumina Human
HT-12 v4 Expression BeadChip Kits. Analysis of omic-
data was done using the IPA software after the application
of a cutoff of 1.5-fold change with comparison of
knockdown samples with siRNA negative control.
Acridine orange (AO) staining
Acidic and autophagic vacuoles emit red fluorescence
when stained with AO stain. Briefly, 0.8–1 × 105 cells
were seeded in a six-well plate and treated with siRNA for
48 h. Cells were then allowed to stay for 15min in serum-
free medium containing 1 μg/ml 3,6-bis(dimethylamine)
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acridine orange and then observed with a Zeiss cell
observer microscope. The excitation filter used was
488 nm and the emission filter was 505–530 nm and
>650 nm.
Hoechst 33342 staining
Following transfection, study the nuclear integrity was
determined by using fluorescent Hoechst stains. Cells in a
density of 0.8–1 × 105 cells were seeded on sterilized cover
slips in six-well plates and allowed to attach and grow
under standard incubation conditions. This was followed
by siRNA treatment 24 h later. After 48 h, the cells were
washed once with PBS and fixed by 4% paraformaldehyde
for 10min. Later, the cells were permeabilized with 0.3%
Triton X-100 in 1ml PBS for 10min, stained with
Hoechst 33342 solution, and kept in a dark environment
for 10min. The cells, grown on cover slips, were placed
top-down on glass slides and photographed with a fluor-
escence microscope (350 nm excitation wavelength).
Reactive oxygen species measurement
2′,7′–Dichlorofluorescin diacetate (DCFH2-DA) is a cell
permeable fluorogenic dye that measures ROS activity
within the cell. In short, 0.8–1 × 105 cells were seeded in a
six-well plate and treated with siRNA for 48 h. A working
solution of 10 μM DCFH2-DA was prepared in serum-
free media. Cells are washed twice in PBS and incubated
for 30min in the dark with DCFH2-DA. The cells were
then washed, harvested and cell pellets suspended in 1ml
PBS. All samples as well as negative and positive controls
were subjected to ROS detection using the 488 nm laser
for excitation and 535 nm for detection with a BD Accuri
C6 flow cytometer.
Annexin V assay
The Annexin V-FITC Kit (Biolegend, 640914) and rh
Annexin V/APC (Invitrogen, BMS306APC-100) allow
detection of apoptotic cells through their affinity to bind
to phosphatidylserine residues, which become exposed
upon apoptosis and then allow their detection and
quantitative determination by fluorescent flow cytometry.
The included PI permits labeling of cellular DNA, which
is a feature of necrosis when the cellular membrane has
been totally compromised. The combined use of both
reagents allows the differentiation between three cell
populations; i.e., early apoptotic, necrotic, and viable cell
populations in response to treatment. Briefly, cells were
seeded in a six-well plate, treated by siRNA and harvested
following 48 h with EDTA free trypsin (0.25%), then
washed once with PBS as well as with 1X binding buffer.
The cells were counted and 2*105 cells were re-suspended
in 100 μl of the 1X binding buffer containing 5 μl Annexin
V-FITC per sample. The cells were incubated for 15 min
at room temperature in the dark, followed by washing
with 1X binding buffer to remove the unbound Annexin
V-FITC, and centrifuged. The cell pellets were resus-
pended in 200 μl of the 1X binding buffer and 5 µl of
propidium iodide/sample (provided with the kit) per
sample. Analyses were done using flowing software.
Statistical analysis
Student’s t-test (2 groups) was used to estimate the sig-
nificance of the group of interest in comparison with a
control group for either viability of the cells, colony for-
mation inhibition or increased migration in the siRNA-
versus nonsense-treated cells. Graphs and calculations were
created using the Graphpad prism version-6 software. P-
values below 0.05 were considered statistically significant.
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